Skip to main content

Journal of Bioscience and Bioengineering

  • Volume 2Issue 12

  • ISSN: 1389-1723

Editor-In-Chief: Akira Ito

  • 5 Year impact factor: 2.6
  • Impact factor: 2.3

The Journal of Bioscience and Bioengineering (JBB) is published by the Society for Biotechnology, Japan and distributed outside Japan by Elsevier.JBB aims to contribute to the… Read more

Subscription options

Institutional subscription on ScienceDirect

Request a sales quote

The Journal of Bioscience and Bioengineering (JBB) is published by the Society for Biotechnology, Japan and distributed outside Japan by Elsevier.

JBB aims to contribute to the advancement and dissemination of knowledge and technology in the fields of bioscience and biotechnology.

It publishes papers on a broad range of topics in the areas of:

Genetics, molecular biology, and gene engineering

Enzymology, protein engineering, and enzyme technology

Microbial physiology and biotechnology

Brewing and food technology

Environmental biotechnology

Biochemical engineering

Plant biotechnology

Cell and tissue engineering

Biomedical engineering


Genomics, systems biology, and structural biology, which hold much promise for the future, are also within the scope of JBB.

The journal only considers submissions that report on the most significant and fundamental advances in the field of bioscience and bioengineering. Manuscripts that describe optimizations related to phenomena of narrow interest using conventional statistical approaches and/or describe exclusively computer simulation with conventional enzyme reaction models or molecular dynamics, will be rejected without peer review.

The brewing and food technology section welcomes research that provide fundamental advances on fermentation, fermented foods and their process developments. Basic studies solely treating the chemical and/or medicinal aspects of food derivatives prepared by conventional pretreatment techniques are not appropriate for JBB.

The cell and tissue engineering section covers research on cell culture engineering as it relates to regenerative medicine. Topics include the technologies for stem cell culture such as mass production, differentiation control, and tissue reconstruction. Studies in the field of pure cell biology and embryology are not appropriate for JBB.

The biomedical engineering section covers topics related to bioprocess engineering in the field of medicine, including biomaterials, scaffolds, artificial organs, drug delivery systems, microfluidics, and micro-fabrication, but not deals with the topics mainly focusing on mechanical engineering. Studies in the field of basic medicine, pharmaceutical sciences, dentistry, and surgical technique are not suitable for JBB. The journal does not consider pathological, clinical, and epidemiological research.